Diabetes UK (2023), together with the American Diabetes Association and the European Association for the Study of Diabetes, defines remission as HbA1c levels remaining below 48 mmol/mol or 6.5% for...
This article was published in BMC Medicine, used a retrospective cohort study approach to examine data between 2000 and 2019 (Subramanian et al, 2023). The author's main driver to conduct this...
When it comes to safety in healthcare, rules, regulations and guidance are essential to help secure protection for patients and healthcare workers. For example, the Health and Safety Executive (2023)...
Data were retrospectively collected from patient cases that were admitted to the gynaecology ward following gynaecology surgery at a tertiary care hospital in the UK, between 1 July 2019 and 30...
The FSRH have produced a service standard for record keeping in sexual and reproductive healthcare consultations (FSRH, 2019a). It recommends clear documentation of clinical history, assessment,...
Evidence to date suggests that the liquid form of iron supplementation has comparable efficacy to the tablet formulation, but with significantly lower gastrointestinal side effects. The evidence...
John (a pseudonym used to protect his identity) was a 54 year-old man who was referred to the mental health crisis resolution team by his GP after attempting suicide. There had been a 1-month history...
In November 2022, van Dyck et al (2022) reported the results of an 18-month, double-blind, phase 3 trial of 1795 participants with early Alzheimer’s disease and evidence of amyloid. Half received...
A visit to my GP recently, which required a prescription, led me to ask myself: when was the last time I held a paper FP10 green prescription in my hand? As someone with a long-term condition...
NICE has recommended a weekly injection for treating growth failure in children. The recommended treatment, known as growth hormone therapy, involves a weekly injection of a hormone called somatropin....
Day 1: In the 1990s, growing insight into incretin roles in type 2 (T2DM) diabetes led to an interest in the breakdown of gut hormone GLP-1. DPP-4 was identified as the best peptidase target and a...
A new study published in the British Medical Journal has examined whether the use of the receptor agonist glucagon-like peptide 1 (GLP-1), dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills